Here's the live share price of Amrutanjan Health Care along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Amrutanjan Health Care has gained 6.18% CAGR. Over the past year, the corresponding return has been -7.61%.
Amrutanjan Health Care’s current P/E of 0.00x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Amrutanjan Health Care | -0.29 | -2.15 | -10.44 | -6.33 | -7.61 | -1.44 | 6.18 |
| Sun Pharmaceutical Industries | -3.21 | -2.45 | 6.80 | 4.59 | -4.41 | 20.27 | 24.12 |
| Divi's Laboratories | 3.16 | 2.12 | 8.52 | -1.10 | 12.27 | 23.69 | 11.61 |
| Torrent Pharmaceuticals | 1.66 | 3.04 | 5.99 | 20.58 | 12.65 | 34.66 | 22.45 |
| Cipla | -0.09 | -0.55 | -2.74 | -0.48 | 1.34 | 10.91 | 12.41 |
| Dr. Reddy's Laboratories | -0.32 | 3.53 | -2.41 | -5.19 | -6.16 | 14.28 | 4.03 |
| Lupin | -0.34 | 5.37 | 5.77 | 9.08 | -2.87 | 41.56 | 16.62 |
| Zydus Lifesciences | -0.10 | -0.99 | -11.37 | -4.92 | -4.87 | 29.70 | 13.38 |
| Mankind Pharma | 4.19 | -0.96 | -13.08 | -4.75 | -24.46 | 15.58 | 9.07 |
| Aurobindo Pharma | 1.42 | 1.31 | 10.86 | 9.60 | -4.14 | 40.40 | 5.89 |
| Alkem Laboratories | -1.08 | -1.09 | -0.16 | 15.83 | 2.90 | 21.81 | 13.77 |
| Abbott India | 3.45 | -3.72 | -5.10 | -9.18 | 0.54 | 9.56 | 12.70 |
| Laurus Labs | 7.56 | 10.69 | 19.40 | 62.17 | 91.40 | 41.66 | 25.52 |
| Glenmark Pharmaceuticals | 3.41 | 9.40 | -0.18 | 19.75 | 31.11 | 67.86 | 32.33 |
| Biocon | 3.02 | 0.86 | 10.92 | 14.09 | 15.44 | 14.51 | -3.75 |
| GlaxoSmithKline Pharmaceuticals | -3.94 | 0.21 | -9.76 | -23.16 | 9.49 | 23.09 | 10.09 |
| Anthem Biosciences | 0.48 | 5.66 | -18.74 | -8.61 | -8.61 | -2.95 | -1.78 |
| Ipca Laboratories | 1.11 | -0.60 | 4.56 | 5.82 | -10.75 | 18.53 | 5.49 |
| Ajanta Pharma | 4.74 | 8.33 | 7.59 | 6.14 | -2.83 | 32.00 | 19.59 |
| J B Chemicals & Pharmaceuticals | 0.89 | 3.29 | 6.77 | 0.62 | -2.99 | 23.13 | 28.52 |
Over the last one year, Amrutanjan Health Care has declined 7.61% compared to peers like Sun Pharmaceutical Industries (-4.41%), Divi's Laboratories (12.27%), Torrent Pharmaceuticals (12.65%). From a 5 year perspective, Amrutanjan Health Care has underperformed peers relative to Sun Pharmaceutical Industries (24.12%) and Divi's Laboratories (11.61%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 682.93 | 681.71 |
| 10 | 673.62 | 678.41 |
| 20 | 672.22 | 679.1 |
| 50 | 696.39 | 691.15 |
| 100 | 706.2 | 698.81 |
| 200 | 694.36 | 700.33 |
In the latest quarter, Amrutanjan Health Care remained same as its previous close in promoter holding, while DII stake increased to 12.90%, FII holding fell to 2.38%, and public shareholding moved down to 38.16% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 14,66,269 | 0.59 | 99.85 | |
| 7,13,715 | 2.48 | 48.6 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Nov 11, 2025, 10:02 PM IST | Amrutanjan Health Ca - Investor Presentation For The Quarter Ended 30Th September 2025 |
| Nov 10, 2025, 10:43 PM IST | Amrutanjan Health Ca - Record Date For The First Interim Dividend Is 18 November 2025. |
| Nov 10, 2025, 10:14 PM IST | Amrutanjan Health Ca - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 |
| Nov 04, 2025, 5:23 PM IST | Amrutanjan Health Ca - Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results Along With The L |
| Oct 18, 2025, 6:27 AM IST | Amrutanjan Health Ca - Disclosure Under Regulation 30 Of SEBI LODR 2015 |
Amrutanjan Health Care Ltd. is a Public Limited Listed company incorporated on 09/09/1936 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24231TN1936PLC000017 and registration number is 000017. Currently Company is involved in the business activities of Manufacture of `ayurvedic' or `unani' pharmaceutical preparation. Company's Total Operating Revenue is Rs. 451.82 Cr. and Equity Capital is Rs. 2.89 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Amrutanjan Health Care is ₹674.60 as on Dec 24, 2025.
The Amrutanjan Health Care is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Amrutanjan Health Care is ₹1,950.31 Cr as on Dec 24, 2025.
Today’s highest and lowest price of Amrutanjan Health Care are ₹684.20 and ₹674.60.
The 52-week high/low is the highest and lowest price at which Amrutanjan Health Care stock has traded in the past 52-week or nearly a year. The 52-week high of Amrutanjan Health Care is ₹829.00 and 52-week low of Amrutanjan Health Care is ₹548.05 as on Dec 24, 2025.
The Amrutanjan Health Care has shown returns of -1.4% over the past day, -2.15% for the past month, -10.44% over 3 months, -7.61% over 1 year, -1.44% across 3 years, and 6.18% over 5 years.
P/E ratio of and PB ratio of Amrutanjan Health Care are 0.00 and 15.48 on Dec 24, 2025. While the company gives a dividend yield of 0.68 per annum.